FDA Device Classification
FDA Proposes Reclassifying Certain Oncology Immunohistochemistry Test Systems from Class III to Class II
The U.S. Food and Drug Administration has issued a proposal to reclassify immunohistochemistry (IHC) test systems that are intended for use with specific approved oncology therapeutic products (product codes MVC, NKF,…
1 source7 claims checked5d ago
7 unverifiable
Biblical perspectiveINSUFFICIENT CONTEXT
Full analysis